FXAIX
Price
$266.59
Change
+$2.29 (+0.87%)
Updated
Sep 11 closing price
Net Assets
859.16B
GSRLX
Price
$13.28
Change
+$0.17 (+1.30%)
Updated
Sep 11 closing price
Net Assets
401.73M
Interact to see
Advertisement

FXAIX vs GSRLX

FXAIX vs GSRLX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. GSRLX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and GSRLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 859B vs. GSRLX (402M). GSRLX pays higher dividends than FXAIX: GSRLX (1.36) vs FXAIX (1.03). FXAIX was incepted earlier than GSRLX: FXAIX (15 years) vs GSRLX (19 years). GSRLX (0.93) is less costly to investors than FXAIX (0.01). GSRLX is a more actively managed with annual turnover of: 35.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than GSRLX: FXAIX (0) vs GSRLX (1000000). FXAIX annual gain was more profitable for investors over the last year : 16.58 vs. GSRLX (1.53). FXAIX return over 5 years is better than : 82.76 vs. GSRLX (1.66).
FXAIXGSRLXFXAIX / GSRLX
Total Expense Ratio0.010.692%
Annual Report Gross Expense Ratio0.010.932%
Fund Existence15 years19 years-
Gain YTD11.79012.35895%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets859B402M213,682%
Annual Yield % from dividends1.031.3676%
Returns for 1 year16.581.531,086%
Returns for 3 years76.9014.93515%
Returns for 5 years82.761.664,979%
Returns for 10 years294.63-21.90-1,346%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGRX1.680.25
+17.48%
Sangrix Inc.
CLOV4.820.11
+2.34%
Clover Health Investments Corp
WKEY6.360.06
+0.95%
WISeKey International Holding Ltd
JBS12.59-0.03
-0.24%
JBS NV Ordinary Shares - Class A
IRD6.04-0.03
-0.49%
Opus Genetics Inc